From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
Distribution Contract Management is designed to easily automate large portfolios and complex distribution networks within process automation, intuitive portal access, and integration to both ERP and GP systems.
ICyte Distribution Contract Management (DCM) is a SaaS-based, market-proven application for managing all aspects of distribution service (DSA) and fee-for-service (FFS) agreements. ICyte Distribution Contract Management combines configurable contract management, metric calculation, scorecarding, waivers/override logging and credit request workflow to enable true end-to-end management of DSA payments. Benefits include:
With ICyte Distribution Contract Management, pharmaceutical manufacturers can automate processing for agreements with pay-for-performance DSA terms. ICyte Distribution Contract Management also supports pre-deal simulation of proposed metrics and contract templates to negotiations. The built-in, out-of-the-box library contains configurable contracts and metrics including:
ICyte Distribution Contract Management is highly configurable and auditable and supports most industry standard metrics out of the box. ICyte Distribution Contract Management simplifies the management of distributor performance by:
Leveraging enriched channel datasets and analytics, ICyte Distribution Contract Management helps trade and distribution teams to
Trade and distribution teams can easily manage even the largest and most complex distribution networks using the ICyte Distribution Contract Management’s robust automation and integration capabilities, including:
Discover More about our Channel Solutions
From the rising costs of distribution and dispensing obstacles to the growing presence of digital pharmacies, direct distribution, and alternative networks, pharmaceutical organizations are trying to pivot in this new environment.
Watch the Webinar
A top-10 pharmaceutical manufacturer had not refreshed their distribution services agreement (DSA) in over a decade. As a result, their distribution model relied on outdated modes of control, did not support the site of care landed product cost and it was not well-positioned to support the future portfolio.
Download the Case Study
